Inventor · disambiguated record
George Kukolj
Also filed as: KUKOLJ GEORGE
21 granted patents·8 pending applications·734 citations·filing 2001–2020
96Inventor score
Files withBOEHRINGER INGELHEIM CA LTD13BOEHRINGER INGELHEIM INT6FRANCOM PAULA3BOECHER WULF OTTO1BOEHRINGER INGELHEIM LTD1
Top patents by PatentIndex Score
29 records- 0198US6479508B1Viral polymerase inhibitorsBOEHRINGER INGELHEIM CA LTD·Filed 2001·Granted Nov 12, 2002·109 cites·37 claims
- 0298US6448281B1Viral polymerase inhibitorsBOEHRINGER INGELHEIM CA LTD·Filed 2001·Granted Sep 10, 2002·112 cites·54 claims
- 0396US7141574B2Viral polymerase inhibitorsBOEHRINGER INGELHEIM CA LTD·Filed 2002·Granted Nov 28, 2006·108 cites·62 claims
- 0496US6794404B2Viral polymerase inhibitorsBOEHRINGER INGELHEIM CA LTD·Filed 2002·Granted Sep 21, 2004·55 cites·46 claims
- 0594US8119607B2Bicyclic nucleosides and nucleotides as therapeutic agentsFRANCOM PAULA·Filed 2009·Granted Feb 21, 2012·100 cites·32 claims
- 0693US7893084B2Viral polymerase inhibitorsBOEHRINGER INGELHEIM CA LTD·Filed 2008·Granted Feb 22, 2011·23 cites·35 claims
- 0792US8415309B2Bicyclic nucleosides and nucleotides as therapeutic agentsFRANCOM PAULA·Filed 2012·Granted Apr 9, 2013·29 cites·26 claims
- 0891US6841566B2Viral polymerase inhibitorsBOEHRINGER INGELHEIM LTD·Filed 2002·Granted Jan 11, 2005·35 cites·62 claims
- 0990US8501699B2Bicyclic nucleosides and nucleotides as therapeutic agentsFRANCOM PAULA·Filed 2012·Granted Aug 6, 2013·27 cites·21 claims
- 1089US7157486B2Viral polymerase inhibitorsBOEHRINGER INGELHEIM CA LTD·Filed 2002·Granted Jan 2, 2007·29 cites·38 claims
- 1188US11597759B2Multispecific antibodies that target HIV GP120 and CD3GILEAD SCIENCES INC·Filed 2020·Granted Mar 7, 2023·2 cites·14 claims
- 1285US7294457B2Direct binding assay for identifying inhibitors of HCV polymeraseBOEHRINGER INGELHEIM CA LTD·Filed 2002·Granted Nov 13, 2007·43 cites·16 claims
- 1384US6706874B2Self-replicating RNA molecule from hepatitis C virusFiled 2001·Granted Mar 16, 2004·11 cites·10 claims
- 1482US7576079B2Viral polymerase inhibitorsBOEHRINGER INGELHEIM CA LTD·Filed 2006·Granted Aug 18, 2009·4 cites·48 claims
- 1582US7386398B2Hepatitis C Virus NS5B polymerase inhibitor binding pocketBOEHRINGER INGELHEIM INT·Filed 2004·Granted Jun 10, 2008·20 cites·15 claims
- 1681US7208309B2Inhibitor-resistant HCV NS3 proteaseBOEHRINGER INGELHEIM INT·Filed 2003·Granted Apr 24, 2007·13 cites·6 claims
- 1780US7439258B2Viral polymerase inhibitorsBOEHRINGER INGELHEIM CA LTD·Filed 2004·Granted Oct 21, 2008·7 cites·30 claims
- 1879US6956117B2Self-replicating RNA molecule from hepatitis C virusBOEHRINGER INGELHEIM CA LTD·Filed 2002·Granted Oct 18, 2005·4 cites·9 claims
- 1975US7344723B2Self-replicating RNA molecule from hepatitis C virusBOEHRINGER INGELHEIM CA LTD·Filed 2004·Granted Mar 18, 2008·2 cites·6 claims
- 2074US7803944B2Viral polymerase inhibitorsBOEHRINGER INGELHEIM INT·Filed 2006·Granted Sep 28, 2010·1 cites·31 claims
- 2166US7919312B2Self-replicating RNA molecule from hepatitis C virusBOEHRINGER INGELHEIM CA LTD·Filed 2006·Granted Apr 5, 2011·0 cites·11 claims
- 2263US2004203020A1Self-replicating RNA molecule from hepatitis C virusBOEHRINGER INGELHEIM CA LTD·Filed 2003·Application pending·0 cites
- 2351US2013029904A1Hcv combination therapyBOEHRINGER INGELHEIM INT·Filed 2010·Application pending·0 cites
- 2450US2016206678A1Hcv combination therapyBOEHRINGER INGELHEIM INT·Filed 2016·Application pending·0 cites
- 2547US2015164884A1Hcv combination therapyBOEHRINGER INGELHEIM INT·Filed 2015·Application pending·0 cites
- 2641US2007212717A1Method for Inhibiting Hepatitis C Virus ReplicationKUKOLJ GEORGE·Filed 2007·Application pending·0 cites
- 2738US2001055756A1Internal de novo initiation sites of the HCV NS5B polymerase and use thereofFiled 2001·Application pending·0 cites
- 2832US2004110126A1Hcv polymerase inhibitor assayFiled 2002·Application pending·0 cites
- 2927US2012135949A1Combination therapy for treating hcv infectionBOECHER WULF OTTO·Filed 2011·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →